www.BuyersGuideChem.com - the directory of chemicals and chemical suppliers. The search engine opens a large data base and offers new supply sources
Sigma_aldrich Logo
Welcome About BGC Terms of Use MSDS Banner Adverts Statistics Impressum Sitemap
BGC > Product Search > Cefepime dihydrochloride 1-hydrate | 123171-59-5
english deutsch español

Suppliers for CAS

123171-59-5

Properties

CAS   123171-59-5 
Formula   C19H24N6O5S2 . 2HCl 

Structure

18 Registered suppliers

Dayang Chem (Hangzhou) Co.,Ltd. P.R.China
rd Cefepime dihydrochloride  
Hangzhou Meite Industry Co., Ltd (Hangzhou Meite Chemical Co., Ltd) P.R.China
rd Cefepime dihydrochloride  
Leap Chem Co., Ltd P.R.China
rd Cefepime dihydrochloride   CD details
Sigma-Aldrich International GmbH Switzerland
rd Cefepime dihydrochloride 1-hydrate  
Molecular Formula: C19H24N6O5S2.2ClH.H2O
Molecular Weight: 571.5
Hazard Symbols: Xi
WGKGermany: 3
HS Code: 29419000
More details are to be found here
X´ian Taicheng Chem Co., Ltd P.R.China
rd Cefepime dihydrochloride  
Molecular Formula: C19H24N6O5S2.2ClH.H2O
Molecular Weight: 571.5
Hazard Symbols: Xi
WGKGermany: 3
HS Code: 29419000
More details are to be found here
Hangzhou Zhongqi Chem Co., Ltd P.R.China
rd Pyrrolidinium,1-[[(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-,chloride hydrochloride, hydrate (1:1  
Molecular Formula: C19H24N6O5S2.2ClH.H2O
Molecular Weight: 571.5
Hazard Symbols: Xi
WGKGermany: 3
HS Code: 29419000
More details are to be found here
Nantong Xindao Biotech Ltd P.R.China
rd Cefepime dihydrochloride 1-hydrate  
Molecular Formula: C19H24N6O5S2.2ClH.H2O
Molecular Weight: 571.5
Hazard Symbols: Xi
WGKGermany: 3
HS Code: 29419000
More details are to be found here
Hangzhou Lingrui Chemical Co., Ltd. P.R.China
rd Cefepime dihydrochloride  
Molecular Formula: C19H24N6O5S2.2ClH.H2O
Molecular Weight: 571.5
Hazard Symbols: Xi
WGKGermany: 3
HS Code: 29419000
More details are to be found here
Skyrun Industrial Co., Ltd. P.R.China
rd Cefepime dihydrochloride  
Molecular Formula: C19H24N6O5S2.2ClH.H2O
Molecular Weight: 571.5
Hazard Symbols: Xi
WGKGermany: 3
HS Code: 29419000
More details are to be found here
BOC Sciences USA
rd Cefepime dihydrochloride 1-hydrate   CD details
Shandong SanYoung Industry Co., Ltd P.R.China
rd Cefepime dihydrochloride  
Description :
Cefepime is an extended-spectrum parenteral cephalosporin antibiotic active in vitro against a broad spectrum of gram-positive and gram-negative aerobic bacteria. Cefepime dosing was 1-4 g/day (0.5-2.0 g twice daily) for adults; ceftazidime dosing was 1-6 g/day (0.5 g every 12 hours to 2.0 g every 8 hours). A limited number of cefepime-treated patients received 2 g every 8 hours. The median length of dosing for both cefepime and ceftazidime was 7 days. Cefepime has a decreased propensity to induce beta-lactamases compared with other beta-lactam antibiotics. Cefepime has a pharmacokinetic disposition similar to that of other renally eliminated cephalosporins, with a half-life of approximately 2 hours. Cefepime has demonstrated clinical efficacy against a variety of infections, including urinary tract infections, pneumonia, and skin structure infections. Cefepime is generally well tolerated.
  • Molecular Weight :571.50
  • Melting Point :150°C(dec.)
  • Purity :> 98%
Molecular Formula :
C19H28Cl2N6O6S2
Canonical SMILES :
C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O.O.Cl.[Cl-]
InChI :
InChI=1S/C19H24N6O5S2.2ClH.H2O/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11;;;/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29);2*1H;1H2/b23-12-;;;/t13-,17-;;;/m1./s1
InChIKey :
LRAJHPGSGBRUJN-OMIVUECESA-N
Solubility :
Soluble in DMSO
Appearance :
White Solid
Storage : Store at -20°C
Synonyms :
Maxipime
More details are to be found here
Carbone Scientific Co., Ltd. U.K.
rd Cefepime dihydrochloride  
Description :
Cefepime is an extended-spectrum parenteral cephalosporin antibiotic active in vitro against a broad spectrum of gram-positive and gram-negative aerobic bacteria. Cefepime dosing was 1-4 g/day (0.5-2.0 g twice daily) for adults; ceftazidime dosing was 1-6 g/day (0.5 g every 12 hours to 2.0 g every 8 hours). A limited number of cefepime-treated patients received 2 g every 8 hours. The median length of dosing for both cefepime and ceftazidime was 7 days. Cefepime has a decreased propensity to induce beta-lactamases compared with other beta-lactam antibiotics. Cefepime has a pharmacokinetic disposition similar to that of other renally eliminated cephalosporins, with a half-life of approximately 2 hours. Cefepime has demonstrated clinical efficacy against a variety of infections, including urinary tract infections, pneumonia, and skin structure infections. Cefepime is generally well tolerated.
  • Molecular Weight :571.50
  • Melting Point :150°C(dec.)
  • Purity :> 98%
Molecular Formula :
C19H28Cl2N6O6S2
Canonical SMILES :
C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O.O.Cl.[Cl-]
InChI :
InChI=1S/C19H24N6O5S2.2ClH.H2O/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11;;;/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29);2*1H;1H2/b23-12-;;;/t13-,17-;;;/m1./s1
InChIKey :
LRAJHPGSGBRUJN-OMIVUECESA-N
Solubility :
Soluble in DMSO
Appearance :
White Solid
Storage : Store at -20°C
Synonyms :
Maxipime
More details are to be found here
Xiamen Equation Chemical Co.,Ltd P.R.China
rd Cefepime dihydrochloride  
Description :
Cefepime is an extended-spectrum parenteral cephalosporin antibiotic active in vitro against a broad spectrum of gram-positive and gram-negative aerobic bacteria. Cefepime dosing was 1-4 g/day (0.5-2.0 g twice daily) for adults; ceftazidime dosing was 1-6 g/day (0.5 g every 12 hours to 2.0 g every 8 hours). A limited number of cefepime-treated patients received 2 g every 8 hours. The median length of dosing for both cefepime and ceftazidime was 7 days. Cefepime has a decreased propensity to induce beta-lactamases compared with other beta-lactam antibiotics. Cefepime has a pharmacokinetic disposition similar to that of other renally eliminated cephalosporins, with a half-life of approximately 2 hours. Cefepime has demonstrated clinical efficacy against a variety of infections, including urinary tract infections, pneumonia, and skin structure infections. Cefepime is generally well tolerated.
  • Molecular Weight :571.50
  • Melting Point :150°C(dec.)
  • Purity :> 98%
Molecular Formula :
C19H28Cl2N6O6S2
Canonical SMILES :
C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O.O.Cl.[Cl-]
InChI :
InChI=1S/C19H24N6O5S2.2ClH.H2O/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11;;;/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29);2*1H;1H2/b23-12-;;;/t13-,17-;;;/m1./s1
InChIKey :
LRAJHPGSGBRUJN-OMIVUECESA-N
Solubility :
Soluble in DMSO
Appearance :
White Solid
Storage : Store at -20°C
Synonyms :
Maxipime
More details are to be found here
AK Scientific, Inc. USA
rd Cefepime dihydrochloride 1-hydrate  
Description :
Cefepime is an extended-spectrum parenteral cephalosporin antibiotic active in vitro against a broad spectrum of gram-positive and gram-negative aerobic bacteria. Cefepime dosing was 1-4 g/day (0.5-2.0 g twice daily) for adults; ceftazidime dosing was 1-6 g/day (0.5 g every 12 hours to 2.0 g every 8 hours). A limited number of cefepime-treated patients received 2 g every 8 hours. The median length of dosing for both cefepime and ceftazidime was 7 days. Cefepime has a decreased propensity to induce beta-lactamases compared with other beta-lactam antibiotics. Cefepime has a pharmacokinetic disposition similar to that of other renally eliminated cephalosporins, with a half-life of approximately 2 hours. Cefepime has demonstrated clinical efficacy against a variety of infections, including urinary tract infections, pneumonia, and skin structure infections. Cefepime is generally well tolerated.
  • Molecular Weight :571.50
  • Melting Point :150°C(dec.)
  • Purity :> 98%
Molecular Formula :
C19H28Cl2N6O6S2
Canonical SMILES :
C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O.O.Cl.[Cl-]
InChI :
InChI=1S/C19H24N6O5S2.2ClH.H2O/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11;;;/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29);2*1H;1H2/b23-12-;;;/t13-,17-;;;/m1./s1
InChIKey :
LRAJHPGSGBRUJN-OMIVUECESA-N
Solubility :
Soluble in DMSO
Appearance :
White Solid
Storage : Store at -20°C
Synonyms :
Maxipime
More details are to be found here
Chemos GmbH & Co. KG Germany
rd Cefepime dihydrochloride  
Description :
Cefepime is an extended-spectrum parenteral cephalosporin antibiotic active in vitro against a broad spectrum of gram-positive and gram-negative aerobic bacteria. Cefepime dosing was 1-4 g/day (0.5-2.0 g twice daily) for adults; ceftazidime dosing was 1-6 g/day (0.5 g every 12 hours to 2.0 g every 8 hours). A limited number of cefepime-treated patients received 2 g every 8 hours. The median length of dosing for both cefepime and ceftazidime was 7 days. Cefepime has a decreased propensity to induce beta-lactamases compared with other beta-lactam antibiotics. Cefepime has a pharmacokinetic disposition similar to that of other renally eliminated cephalosporins, with a half-life of approximately 2 hours. Cefepime has demonstrated clinical efficacy against a variety of infections, including urinary tract infections, pneumonia, and skin structure infections. Cefepime is generally well tolerated.
  • Molecular Weight :571.50
  • Melting Point :150°C(dec.)
  • Purity :> 98%
Molecular Formula :
C19H28Cl2N6O6S2
Canonical SMILES :
C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O.O.Cl.[Cl-]
InChI :
InChI=1S/C19H24N6O5S2.2ClH.H2O/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11;;;/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29);2*1H;1H2/b23-12-;;;/t13-,17-;;;/m1./s1
InChIKey :
LRAJHPGSGBRUJN-OMIVUECESA-N
Solubility :
Soluble in DMSO
Appearance :
White Solid
Storage : Store at -20°C
Synonyms :
Maxipime
More details are to be found here
BuGuCh & Partners Germany
rd Cefepime dihydrochloride  
Description :
Cefepime is an extended-spectrum parenteral cephalosporin antibiotic active in vitro against a broad spectrum of gram-positive and gram-negative aerobic bacteria. Cefepime dosing was 1-4 g/day (0.5-2.0 g twice daily) for adults; ceftazidime dosing was 1-6 g/day (0.5 g every 12 hours to 2.0 g every 8 hours). A limited number of cefepime-treated patients received 2 g every 8 hours. The median length of dosing for both cefepime and ceftazidime was 7 days. Cefepime has a decreased propensity to induce beta-lactamases compared with other beta-lactam antibiotics. Cefepime has a pharmacokinetic disposition similar to that of other renally eliminated cephalosporins, with a half-life of approximately 2 hours. Cefepime has demonstrated clinical efficacy against a variety of infections, including urinary tract infections, pneumonia, and skin structure infections. Cefepime is generally well tolerated.
  • Molecular Weight :571.50
  • Melting Point :150°C(dec.)
  • Purity :> 98%
Molecular Formula :
C19H28Cl2N6O6S2
Canonical SMILES :
C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O.O.Cl.[Cl-]
InChI :
InChI=1S/C19H24N6O5S2.2ClH.H2O/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11;;;/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29);2*1H;1H2/b23-12-;;;/t13-,17-;;;/m1./s1
InChIKey :
LRAJHPGSGBRUJN-OMIVUECESA-N
Solubility :
Soluble in DMSO
Appearance :
White Solid
Storage : Store at -20°C
Synonyms :
Maxipime
More details are to be found here
CM Fine Chemicals Switzerland
rd Cefepime dihydrochloride  
Description :
Cefepime is an extended-spectrum parenteral cephalosporin antibiotic active in vitro against a broad spectrum of gram-positive and gram-negative aerobic bacteria. Cefepime dosing was 1-4 g/day (0.5-2.0 g twice daily) for adults; ceftazidime dosing was 1-6 g/day (0.5 g every 12 hours to 2.0 g every 8 hours). A limited number of cefepime-treated patients received 2 g every 8 hours. The median length of dosing for both cefepime and ceftazidime was 7 days. Cefepime has a decreased propensity to induce beta-lactamases compared with other beta-lactam antibiotics. Cefepime has a pharmacokinetic disposition similar to that of other renally eliminated cephalosporins, with a half-life of approximately 2 hours. Cefepime has demonstrated clinical efficacy against a variety of infections, including urinary tract infections, pneumonia, and skin structure infections. Cefepime is generally well tolerated.
  • Molecular Weight :571.50
  • Melting Point :150°C(dec.)
  • Purity :> 98%
Molecular Formula :
C19H28Cl2N6O6S2
Canonical SMILES :
C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O.O.Cl.[Cl-]
InChI :
InChI=1S/C19H24N6O5S2.2ClH.H2O/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11;;;/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29);2*1H;1H2/b23-12-;;;/t13-,17-;;;/m1./s1
InChIKey :
LRAJHPGSGBRUJN-OMIVUECESA-N
Solubility :
Soluble in DMSO
Appearance :
White Solid
Storage : Store at -20°C
Synonyms :
Maxipime
More details are to be found here
Santa Cruz Biotechnology, Inc. USA
rd Cefepime dihydrochloride 1-hydrate  
Description :
Cefepime is an extended-spectrum parenteral cephalosporin antibiotic active in vitro against a broad spectrum of gram-positive and gram-negative aerobic bacteria. Cefepime dosing was 1-4 g/day (0.5-2.0 g twice daily) for adults; ceftazidime dosing was 1-6 g/day (0.5 g every 12 hours to 2.0 g every 8 hours). A limited number of cefepime-treated patients received 2 g every 8 hours. The median length of dosing for both cefepime and ceftazidime was 7 days. Cefepime has a decreased propensity to induce beta-lactamases compared with other beta-lactam antibiotics. Cefepime has a pharmacokinetic disposition similar to that of other renally eliminated cephalosporins, with a half-life of approximately 2 hours. Cefepime has demonstrated clinical efficacy against a variety of infections, including urinary tract infections, pneumonia, and skin structure infections. Cefepime is generally well tolerated.
  • Molecular Weight :571.50
  • Melting Point :150°C(dec.)
  • Purity :> 98%
Molecular Formula :
C19H28Cl2N6O6S2
Canonical SMILES :
C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O.O.Cl.[Cl-]
InChI :
InChI=1S/C19H24N6O5S2.2ClH.H2O/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11;;;/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29);2*1H;1H2/b23-12-;;;/t13-,17-;;;/m1./s1
InChIKey :
LRAJHPGSGBRUJN-OMIVUECESA-N
Solubility :
Soluble in DMSO
Appearance :
White Solid
Storage : Store at -20°C
Synonyms :
Maxipime
More details are to be found here
Detailed information on the suppliers of Cefepime dihydrochloride 1-hydrate

Properties:

... more properties and specification on Cefepime dihydrochloride 1-hydrate
© Copyright 1996 to 2024 by Netvertise GmbH. All rights reserved